SCN5A Variant G874D
Summary of observed carriers, functional annotations, and structural context for SCN5A G874D. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
5%
0/12 effective observations
Estimated BrS1 penetrance
11%
1/12 effective observations
Total carriers
2
0 BrS1 · 0 LQT3 · 2 unaffected
Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
|---|---|---|---|---|---|
| -1.11 | 0.003 | -0.13 | 0.663 | 12 | 0 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
|---|---|---|---|---|---|---|---|
| Literature, cohort, and gnomAD | – | 2 | 2 | 0 | 0 | – | |
| Variant features alone | – | 15 | 14 | 0 | 1 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
| Neighbour residue | Distance (Å) | Observed variants |
|---|---|---|
| 880 | 12 | |
| 870 | 6 | |
| 867 | 14 | E867K, E867Q, E867X, |
| 1440 | 13 | W1440X, |
| 864 | 14 | |
| 871 | 5 | |
| 909 | 12 | |
| 876 | 7 | |
| 868 | 10 | c.2602delC, L868X, |
| 882 | 15 | |
| 872 | 6 | D872N, |
| 865 | 11 | |
| 866 | 12 | S866P, S866L, |
| 874 | 0 | G874D, |
| 878 | 12 | R878C, R878H, R878L, |
| 350 | 14 | H350Q, H350Q, |
| 1441 | 15 | E1441Q |
| 877 | 8 | |
| 879 | 15 | W879R, W879R, |
| 869 | 8 | R869S, R869S, |
| 905 | 12 | |
| 875 | 4 | |
| 908 | 11 | |
| 873 | 4 | S873A, |